None
Quote | AgeX Therapeutics Inc. (NYSE:AGE)
Last: | $11.10 |
---|---|
Change Percent: | -13.42% |
Open: | $12.59 |
Close: | $11.10 |
High: | $12.59 |
Low: | $11.1 |
Volume: | 3,753 |
Last Trade Date Time: | 03/26/2024 03:00:00 am |
News | AgeX Therapeutics Inc. (NYSE:AGE)
Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024 Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the fourth quarter of 2024; IND submission to the FDA for the initiation of a Phas...
2024-03-25 00:59:35 ET More on AgeX Therapeutics Financial information for AgeX Therapeutics Read the full article on Seeking Alpha For further details see: AgeX Therapeutics GAAP EPS of -$13.73
Message Board Posts | AgeX Therapeutics Inc. (NYSE:AGE)
Subject | By | Source | When |
---|---|---|---|
New worldwide patents on DR-iTR and EPRO | saxonia40271 | investorshub | 04/22/2023 5:35:00 AM |
New Australian Patent | saxonia40271 | investorshub | 03/14/2023 7:55:23 AM |
Innovative delivery methods in the works | saxonia40271 | investorshub | 02/28/2023 4:35:37 PM |
Longevity Summit Dublin 2023 coming up! | saxonia40271 | investorshub | 02/27/2023 1:27:06 PM |
Aubrey de Grey posts on the RMR study | saxonia40271 | investorshub | 02/27/2023 1:21:45 PM |
News, Short Squeeze, Breakout and More Instantly...
Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024 Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the fourth quarter of 2024; IND submission to the FDA for the initiation of a Phas...
ALAMEDA, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter and the full year ended Decembe...
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...